                         SEQUENCE LISTING

<110>  Massachusetts Eye and Ear Infirmary
 
<120>  Fibroblast growth factor 2 (FGF2) for Treatment of Human 
       Sensorineural Hearing Loss

<130>  00633-0264WO1

<140>  PCT/US2020/035198
<141>  2020-05-29

<150>  US 62/854,287
<151>  2019-05-29

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  146
<212>  PRT
<213>  Artificial

<220>
<223>  Pro143-Ser288 of human FGF2

<400>  1

Pro Ala Leu Pro Glu Asp Gly Gly Ser Gly Ala Phe Pro Pro Gly His 
1               5                   10                  15      


Phe Lys Asp Pro Lys Arg Leu Tyr Cys Lys Asn Gly Gly Phe Phe Leu 
            20                  25                  30          


Arg Ile His Pro Asp Gly Arg Val Asp Gly Val Arg Glu Lys Ser Asp 
        35                  40                  45              


Pro His Ile Lys Leu Gln Leu Gln Ala Glu Glu Arg Gly Val Val Ser 
    50                  55                  60                  


Ile Lys Gly Val Cys Ala Asn Arg Tyr Leu Ala Met Lys Glu Asp Gly 
65                  70                  75                  80  


Arg Leu Leu Ala Ser Lys Cys Val Thr Asp Glu Cys Phe Phe Phe Glu 
                85                  90                  95      


Arg Leu Glu Ser Asn Asn Tyr Asn Thr Tyr Arg Ser Arg Lys Tyr Thr 
            100                 105                 110         


Ser Trp Tyr Val Ala Leu Lys Arg Thr Gly Gln Tyr Lys Leu Gly Ser 
        115                 120                 125             


Lys Thr Gly Pro Gly Gln Lys Ala Ile Leu Phe Leu Pro Met Ser Ala 
    130                 135                 140                 


Lys Ser 
145     


